Filtered By:
Vaccination: Measles Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 85 results found since Jan 2013.

Evaluation of Children with Cow's Milk Allergy Who Received Measles or Measles, Mumps, and Rubella Vaccines Containing Alpha-Lactalbumin
Pediatric Allergy, Immunology, and Pulmonology, Ahead of Print.
Source: Pediatric, Allergy, Immunology, and Pulmonology - July 11, 2023 Category: Respiratory Medicine Authors: Ezgi Ulusoy Severcan Aysegul Ertugrul Serap Ozmen Source Type: research

The Conspirituality of Robert F. Kennedy Jr.
This article has been adapted from Chapter 23 of Conspirituality: How New Age Conspiracy Theories Became a Health Threat by Derek Beres, Matthew Remski, and Julian Walker. Copyright © 2023. Available from PublicAffairs, an imprint of Hachette Book Group, Inc.
Source: TIME: Health - July 5, 2023 Category: Consumer Health News Authors: Derek Beres, Matthew Remski, and Julian Walker Tags: Uncategorized freelance politics Source Type: news

AAP Approves 2023 Child and Adolescent Immunization Schedule AAP Approves 2023 Child and Adolescent Immunization Schedule
Minor changes and additions to annual ACIP recommendations affected vaccines for COVID-19; dengue fever; pneumococcal disease; and measles, mumps, and rubella.Medscape Medical News
Source: Medscape Allergy Headlines - February 9, 2023 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news

Measles in the United States: Should We Worry? Measles in the United States: Should We Worry?
Paul G. Auwaerter, MD, discusses measles, vaccination, and herd immunity.Medscape Infectious Diseases
Source: Medscape Allergy Headlines - February 6, 2023 Category: Allergy & Immunology Tags: Infectious Diseases Commentary Source Type: news

Implementation of a quality improvement programme using the Active Patient Link call and recall system to improve timeliness and equity of childhood vaccinations: protocol for a mixed-methods evaluation
Introduction Call and recall systems provide actionable intelligence to improve equity and timeliness of childhood vaccinations, which have been disrupted during the COVID-19 pandemic. We will evaluate the effectiveness, fidelity and sustainability of a data-enabled quality improvement programme delivered in primary care using an Active Patient Link Immunisation (APL-Imms) call and recall system to improve timeliness and equity of uptake in a multiethnic disadvantaged urban population. We will use qualitative methods to evaluate programme delivery, focusing on uptake and use, implementation barriers and service improvement...
Source: BMJ Open - January 20, 2023 Category: General Medicine Authors: Marszalek, M., Hawking, M. K. D., Gutierrez, A., Dostal, I., Ahmed, Z., Firman, N., Robson, J., Bedford, H., Billington, A., Moss, N., Dezateux, C. Tags: Open access, Immunology (including allergy) Source Type: research

U.S. weighs crackdown on experiments that could make viruses more dangerous
.news-article__hero--featured .parallax__element{ object-position: 50% 40%; -o-object-position: 50% 40%; } .scroll-wrapper { overflow-x: auto; } .scroll-wrapper .news-article__figure__image{ width: 2680px; max-width: none; padding-bottom: .75rem; } .scroll-fade-before, .scroll-fade-after { position: absolute; width: 1.5rem; transition-duration: .1s; opacity: 1; } .scroll-fade-before { left: 1rem; /*margin-left: -1px;*/ background: linear-gradient(90deg, #fff, #fff 35%, hsla(0, 0%, 100%, 0)); } .scroll-fade-after { right: 1rem; /*margin-right: -1px;*/ background: linear-gradient(270deg, #fff, #fff 35%, hsla(0,...
Source: ScienceNOW - October 19, 2022 Category: Science Source Type: news

Split-Dosing of COVID-19 Vaccines Provides Non-Inferior Antibody Responsiveness to Conventional Vaccine Dosing
coronavirus disease 2019 (COVID-19), messenger RNA (mRNA), polyethylene glycol (PEG), American College of Allergy, Asthma, and Immunology (ACAAI), Receptor Binding Domain Protein (RBD), Spike Protein 1 (S1), Nucleocapsid (N), mean fluorescent intensity (MFI), natural infection (NI), significant differences in mean (SEM), MMR (measles, mumps, rubella), inhaled corticosteroids (ICS)
Source: Annals of Allergy, Asthma and Immunology - September 6, 2022 Category: Allergy & Immunology Authors: Amal Musa, Macy Wood, Andrew Rorie, Sara M. May, Joel Van De Graaff, Jill A. Poole Tags: Letters Source Type: research

True, true, and unrelated: Stop routine testing to vaccine excipients for suspected vaccine allergy
Vaccines for infectious diseases contain multiple minor ingredients called excipients, such as egg ovalbumin, polysorbate (PS), polyethylene glycol (PEG), neomycin, thimerosal, and other contaminants (eg, lactose, yeast, formaldehyde, gelatin, latex).1,2 Allergic reactions occurring to vaccines are rare, but focus on vaccine excipients as the provoking cause.3 Examples of this include egg ovalbumin in yellow fever (YF), gelatin in measles, mumps, and rubella (MMR) and several other vaccines, yeast in hepatitis B vaccines, and casein with diphtheria tetanus acellular pertussis (DTaP).
Source: Annals of Allergy, Asthma and Immunology - June 16, 2022 Category: Allergy & Immunology Authors: Matthew Greenhawt Tags: Perspective Source Type: research

Gelatin-Containing Vaccines for Varicella, Zoster, Measles, Mumps, and Rubella Induce Basophil Activation in Patients with Alpha-Gal Syndrome
Conclusions: Gelatin-containing vaccines should be administered with caution or avoided in patients with AGS because of their high potential to activate basophils indicating a risk for anaphylaxis. Also, BAT is a useful additional tool when it comes to screening for potentially high-risk alpha-gal-containing drugs.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - March 18, 2021 Category: Allergy & Immunology Source Type: research

We May Never Eliminate COVID-19. But We Can Learn to Live With It
When does a pandemic end? Is it when life regains a semblance of normality? Is it when the world reaches herd immunity, the benchmark at which enough people are immune to an infectious disease to stop its widespread circulation? Or is it when the disease is defeated, the last patient cured and the pathogen retired to the history books? The last scenario, in the case of COVID-19, is likely a ways off, if it ever arrives. The virus has infected more than 100 million people worldwide and killed more than 2 million. New viral variants even more contagious than those that started the pandemic are spreading across the world. And...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cover Story COVID-19 feature Magazine Source Type: news

Revaccination following suspected vaccine-triggered hypersensitivity reactions: experience of a tertiary care centre.
CONCLUSIONS: Most incidents of skin rashes after immunisation are not suggestive of actual HRs. The results in the current study showed that the majority of the patients presenting with suspected HRs tolerated revaccination, including those with a previous history of suspected anaphylaxis. Revaccination of these patients is safe with adequate precautions. It is absolutely essential to be equipped for the management of anaphylaxis. PMID: 33528940 [PubMed - as supplied by publisher]
Source: Allergologia et Immunopathologia - February 3, 2021 Category: Allergy & Immunology Authors: Ertugrul A, Cavkaytar O, Bostanci İ, Özmen S Tags: Allergol Immunopathol (Madr) Source Type: research

Principles and Challenges in anti-COVID-19 Vaccine Development
The number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients keeps rising in most of the European countries despite the pandemic precaution measures. The current antiviral and anti-inflammatory therapeutic approaches are only supportive, have limited efficacy, and the prevention in reducing the transmission of SARS-CoV-2 virus is the best hope for public health. It is presumed that an effective vaccination against SARS-CoV-2 infection could mobilize the innate and adaptive immune responses and provide a protection against severe forms of coronavirus disease 2019 (COVID-19) disease. As the ra...
Source: International Archives of Allergy and Immunology - February 1, 2021 Category: Allergy & Immunology Source Type: research

Recent Mumps-Measles-Rubella Vaccination Probably Reduces COVID-19 Severity: A Proposed Strategy For Close-Contacts Of Patients
several of the proteins produced by the SARS-CoV-2 virus inhibit interferon (IFN) and IFN gene responses, thus abating the innate immune response during the initial infection. Several US and European investigators have reported in the past trained immunity after BCG or measles vaccination: an enhanced non-specific (innate) immune response to non-related pathogens, which for BCG can last a year. However, BCG might be too strong a stimulus which we preferred not to use in the light of the cytokine storm-like syndrome in some patients with advanced COVID-19.
Source: Journal of Allergy and Clinical Immunology - February 1, 2021 Category: Allergy & Immunology Authors: Desiree Larenas - Linnemann, Fernanda Rodr íguez Monroy Source Type: research

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news